文献速递胸部肿瘤

PanCan研究:风险模型筛选肺癌筛查人群的前瞻性单臂研究

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
PubMed 文献 · Lancet Oncol · 2017-10-18

PanCan研究是一项在加拿大8个中心开展的单臂前瞻性研究,纳入2537名50-75岁、经PanCan模型评估6年肺癌风险≥2%的曾吸烟者,基线及第1、4年行低剂量CT筛查。

要点

  • 172例肺癌中133例(77%)为早期(I或II期),高于NLST的593/1040(57%)。

核心结论

  • PanCan模型可有效识别随后诊断为早期、潜在可治愈肺癌的个体。
  • 筛查人群中检出的肺癌发病率及早期肺癌比例高于既往研究。
  • 该方法应考虑用于肺癌筛查项目。

研究设计与样本

  • 单臂、前瞻性研究,在加拿大8个中心开展。
  • 招募50-75岁曾吸烟者,无自报肺癌史,PanCan模型评估6年肺癌风险至少2%。
  • 基线(T0)、第1年(T1)和第4年(T4)行低剂量CT筛查。
  • 主要结局为肺癌发病率;研究注册号NCT00751660。

主要发现

  • Interval肺癌10例(占肺癌6%,占患癌个体6%):T0-T1间1例,T1-T4间9例。

临床怎么用

  • 原文结论为PanCan模型可有效识别随后诊断为早期、潜在可治愈肺癌的个体。
  • 原文建议该方法应考虑用于肺癌筛查项目。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Results from retrospective studies indicate that selecting individuals for low-dose CT lung cancer screening on the basis of a highly predictive risk model is superior to using criteria similar to those used in the National Lung Screening Trial (NLST; age, pack-year, and smoking quit-time). We designed the Pan-Canadian Early Detection of Lung Cancer (PanCan) study to assess the efficacy of a risk prediction model to select candidates for lung cancer screening, with the aim of determining whether this approach could better detect patients with early, potentially curable, lung cancer. METHODS: We did this single-arm, prospective study in eight centres across Canada. We recruited participants aged 50-75 years, who had smoked at some point in their life (ever-smokers), and who did not have a self-reported history of lung cancer. Participants had at least a 2% 6-year risk of lung cancer as estimated by the PanCan model, a precursor to the validated PLCOm2012 model. Risk variables in the model were age, smoking duration, pack-years, family history of lung cancer, education level, body-mass index, chest x-ray in the past 3 years, and history of chronic obstructive pulmonary disease. Individuals were screened with low-dose CT at baseline (T0), and at 1 (T1) and 4 (T4) years post-baseline. The primary outcome of the study was incidence of lung cancer. This study is registered with ClinicalTrials.gov, number NCT00751660. FINDINGS: 7059 queries came into the study coordinating centre and were screened for PanCan risk. 15 were duplicates, so 7044 participants were considered for enrolment. Between Sept 24, 2008, and Dec 17, 2010, we recruited and enrolled 2537 eligible ever-smokers. After a median follow-up of 5·5 years (IQR 3·2-6·1), 172 lung cancers were diagnosed in 164 individuals (cumulative incidence 0·065 [95% CI 0·055-0·075], incidence rate 138·1 per 10 000 person-years [117·8-160·9]). There were ten interval lung cancers (6% of lung cancers and 6% of individuals with cancer): one diagnosed between T0 and T1, and nine between T1 and T4. Cumulative incidence was significantly higher than that observed in NLST (4·0%; p<0·0001). Compared with 593 (57%) of 1040 lung cancers observed in NLST, 133 (77%) of 172 lung cancers in the PanCan Study were early stage (I or II; p<0·0001). INTERPRETATION: The PanCan model was effective in identifying individuals who were subsequently diagnosed with early, potentially curable, lung cancer. The incidence of cancers detected and the proportion of early stage cancers in the screened population was higher than observed in previous studies. This approach should be considered for adoption in lung cancer screening programmes. FUNDING: Terry Fox Research Institute and Canadian Partnership Against Cancer.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Tammemagi MC, Schmidt H, Martel S, et al. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol. 2017. PMID: 29055736. doi:10.1016/S1470-2045(17)30597-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。